{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:32:25Z","timestamp":1793298745924,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39786-9","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:15:25Z","timestamp":1776449725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["1H NMR-based serum metabolomics identifies discriminatory metabolic signatures associated with pancreatic cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Sudhir Kumar","family":"Shekhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhai","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilutpal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"issue":"1","key":"39786_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74(1), 12\u201349. https:\/\/doi.org\/10.3322\/caac.21820 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"39786_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000319414","volume":"28","author":"GJ Krejs","year":"2010","unstructured":"Krejs, G. J. Pancreatic cancer: Epidemiology and risk factors. Dig. Dis. 28(2), 355\u2013358 (2010).","journal-title":"Dig. Dis."},{"issue":"2","key":"39786_CR3","first-page":"117","volume":"17","author":"H Popescu-v\u00e2lceanu","year":"2015","unstructured":"Popescu-v\u00e2lceanu, H., Nan, R. & Dragut, R. Pancreatic Cancer: Epidemiology and risk factors. Proc. Rom. Acad. 17(2), 117\u2013124 (2015).","journal-title":"Proc. Rom. Acad."},{"issue":"01","key":"39786_CR4","doi-asserted-by":"publisher","first-page":"07","DOI":"10.4103\/sajc.sajc_382_18","volume":"9","author":"TA Dinesh","year":"2020","unstructured":"Dinesh, T. A., Nair, P., Abhijath, V., Jha, V. & Aarthy, K. Economics of cancer care: A community-based cross-sectional study in Kerala, India. South Asian J. Cancer 9(01), 07\u201312 (2020).","journal-title":"South Asian J. Cancer"},{"issue":"2","key":"39786_CR5","first-page":"71","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal, A. et al. Cancer statistics, 2008. CA: Cancer J. Clin. 58(2), 71\u201396 (2008).","journal-title":"CA: Cancer J. Clin."},{"issue":"10","key":"39786_CR6","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.3390\/cancers14102539","volume":"14","author":"KP Farr","year":"2022","unstructured":"Farr, K. P. et al. Imaging modalities for early detection of pancreatic cancer: Current state and future research opportunities. Cancers 14(10), 2539 (2022).","journal-title":"Cancers"},{"issue":"4","key":"39786_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jprot.2011.10.027","volume":"75","author":"A Zhang","year":"2012","unstructured":"Zhang, A., Sun, H., Wang, P., Han, Y. & Wang, X. Recent and potential developments of biofluid analyses in metabolomics. J. Proteomics 75(4), 1079\u20131088 (2012).","journal-title":"J. Proteomics"},{"issue":"7","key":"39786_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd.2016.32","volume":"15","author":"DS Wishart","year":"2016","unstructured":"Wishart, D. S. Emerging applications of metabolomics in drug discovery and precision medicine. Nat. Rev. Drug Discovery 15(7), 473\u2013484 (2016).","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"10","key":"39786_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.3927","volume":"32","author":"GF Giskeodeg\u00e5rd","year":"2019","unstructured":"Giskeodeg\u00e5rd, G. F. et al. NMR-based metabolomics of biofluids in cancer. NMR Biomed. 32(10), e3927 (2019).","journal-title":"NMR Biomed."},{"key":"39786_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.procbio.2020.08.023","volume":"99","author":"G Raja","year":"2020","unstructured":"Raja, G., Jung, Y., Jung, S. H. & Kim, T.-J. H-NMR-based metabolomics for cancer targeting and metabolic engineering \u2013A review. Process BiochemistryVolume 99, 112\u2013122 (2020).","journal-title":"Process BiochemistryVolume"},{"issue":"5","key":"39786_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2(5), e1600200 (2016).","journal-title":"Sci. Adv."},{"issue":"5","key":"39786_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144(5), 646\u2013674 (2011).","journal-title":"Cell"},{"issue":"3191","key":"39786_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg, O. On the origin of cancer cells. Science 123(3191), 309\u2013314 (1956).","journal-title":"Science"},{"issue":"1","key":"39786_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metab. 23(1), 27\u201347 (2016).","journal-title":"Cell Metab."},{"key":"39786_CR15","doi-asserted-by":"publisher","first-page":"113080","DOI":"10.1016\/j.jpba.2019.113080","volume":"180","author":"U Kumar","year":"2020","unstructured":"Kumar, U. et al. Circulatory Glutamine\/Glucose ratio for evaluating disease activity in Takayasu arteritis: A NMR based serum metabolomics study. J. Pharm. Biomed. Anal. 180, 113080 (2020).","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"12","key":"39786_CR16","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.3390\/cancers16122240","volume":"16","author":"A Mukund","year":"2024","unstructured":"Mukund, A. et al. Pancreatic ductal adenocarcinoma (PDAC): A review of recent advancements enabled by artificial intelligence. Cancers 16(12), 2240. https:\/\/doi.org\/10.3390\/cancers16122240 (2024).","journal-title":"Cancers"},{"key":"39786_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12964-024-01760-1","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. The signifcant role of amino acid metabolic reprogramming in cance. Cell Commun. Signal. 22, 380. https:\/\/doi.org\/10.1186\/s12964-024-01760-1 (2024).","journal-title":"Cell Commun. Signal."},{"issue":"2","key":"39786_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","volume":"15","author":"JL Spratlin","year":"2009","unstructured":"Spratlin, J. L., Serkova, N. J. & Eckhardt, S. G. Clinical applications of metabolomics in oncology: A review. Clin. Cancer Res. 15(2), 431\u2013440 (2009).","journal-title":"Clin. Cancer Res."},{"key":"39786_CR19","doi-asserted-by":"publisher","first-page":"D521","DOI":"10.1093\/nar\/gkl923","volume":"35","author":"DS Wishart","year":"2007","unstructured":"Wishart, D. S. et al. HMDB: The human metabolome database. Nucleic Acids Res. 35, D521\u2013D526 (2007).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"39786_CR20","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang, Z. et al. MetaboAnalyst 6.0: Towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 52(W1), W398\u2013W406 (2024).","journal-title":"Nucleic Acids Res."},{"key":"39786_CR21","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39786-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39786-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39786-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:21:33Z","timestamp":1781047293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39786-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39786"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39786-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"My study entitled \u201cMetabolomic study of pancreatic cancer by\n                      1\n                      H NMR for early detection\u201d was approved by Intuitional Ethics Committee. Letter No. 606\/Ethics\/19, Ref. Code:\n                      96\n                      \n                        th\n                      \n                      ECM II A\/ P 44.\n                      (Approval for blood serum).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"17919"}}